Guggenheim Capital’s Royalty Pharma RPRX Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | – | Sell |
|
|||||
|
2025
Q1 | $1.91M | Sell |
|
|||||
|
2024
Q4 | $1.86M | Sell |
|
|||||
|
2024
Q3 | $4.41M | Buy |
|
|||||
|
2024
Q2 | $3.98M | Buy |
|
|||||
|
2024
Q1 | $3.76M | Buy |
|
|||||
|
2023
Q4 | $2.85M | Sell |
|
|||||
|
2023
Q3 | $3.59M | Buy |
|
|||||
|
2023
Q2 | $3.42M | Buy |
|
|||||
|
2023
Q1 | $3.99M | Sell |
|
|||||
|
2022
Q4 | $5M | Buy |
|
|||||
|
2022
Q3 | $3.84M | Sell |
|
|||||
|
2022
Q2 | $5.09M | Sell |
|
|||||
|
2022
Q1 | $5.1M | Sell |
|
|||||
|
2021
Q4 | $5.76M | Buy |
|
|||||
|
2021
Q3 | $4.31M | Buy |
|
|||||
|
2021
Q2 | $372K | Buy |
|